首页|期刊导航|中国结合医学杂志(英文版)|Sennoside A Ameliorates Diabetic Atherosclerosis by Inhibiting OSCP1/ERK1/2 Pathway to Regulate Endothelial Dysfunction
中国结合医学杂志(英文版)2026,Vol.32Issue(5):431-441,11.DOI:10.1007/s11655-026-4226-5
Sennoside A Ameliorates Diabetic Atherosclerosis by Inhibiting OSCP1/ERK1/2 Pathway to Regulate Endothelial Dysfunction
Sennoside A Ameliorates Diabetic Atherosclerosis by Inhibiting OSCP1/ERK1/2 Pathway to Regulate Endothelial Dysfunction
摘要
关键词
sennoside A/type 2 diabetes mellitus/atherosclerosis/endothelial dysfunctions/organic solute carrier partner 1Key words
sennoside A/type 2 diabetes mellitus/atherosclerosis/endothelial dysfunctions/organic solute carrier partner 1引用本文复制引用
LIU Mei-zhi,MA Li,MI Meng,JIANG Ya-ning,WANG Zi-yang,SUN Yong-ning..Sennoside A Ameliorates Diabetic Atherosclerosis by Inhibiting OSCP1/ERK1/2 Pathway to Regulate Endothelial Dysfunction[J].中国结合医学杂志(英文版),2026,32(5):431-441,11.基金项目
Supported by the National Natural Science Foundation of China(Nos.82074164,82274295 and 82104649),Shaanxi Province Innovation Capability Support Program Project(Youth Science and Technology New Star,No.2023KJXX-108),and the Shaanxi Provincial Administration of Traditional Chinese Medicine(No.SZY-KJCYC-2023-085) (Nos.82074164,82274295 and 82104649)